A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy.
about
Immune restoration diseases reflect diverse immunopathological mechanisms.Cryopreservation decreases receptor PD-1 and ligand PD-L1 coinhibitory expression on peripheral blood mononuclear cell-derived T cells and monocytes.Is there any room for therapeutic vaccination against the HIV-1/AIDS?Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.
P2860
A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A T2 cytokine environment may ...... nse to antiretroviral therapy.
@en
A T2 cytokine environment may ...... nse to antiretroviral therapy.
@nl
type
label
A T2 cytokine environment may ...... nse to antiretroviral therapy.
@en
A T2 cytokine environment may ...... nse to antiretroviral therapy.
@nl
prefLabel
A T2 cytokine environment may ...... nse to antiretroviral therapy.
@en
A T2 cytokine environment may ...... nse to antiretroviral therapy.
@nl
P2093
P2860
P1433
P1476
A T2 cytokine environment may ...... nse to antiretroviral therapy.
@en
P2093
Andrew F Y Lim
Elizabeth J McKinnon
Niamh M Keane
Patricia Price
Silvia Lee
P2860
P356
10.1111/J.1365-2567.2006.02407.X
P577
2006-06-22T00:00:00Z